Anti-PD-1/PD-L1 and anti-CTLA-4 associated checkpoint inhibitor pneumonitis in non-small cell lung cancer: Occurrence, pathogenesis and risk factors (Review)

Immune checkpoint inhibitors (ICIs) play a significant anti-tumor role in the management of non-small cell lung cancer. The most broadly used ICIs are anti-programmed death 1 (PD-1), anti-programmed cell death-ligand 1, and anti-cytotoxic T lymphocyte-associated antigen-4 monoclonal antibody. Compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiao, Ren, Jin, Xue, Qianfei, Luan, Rumei, Ding, Dongyan, Tan, Jie, Su, Xin, Yang, Junling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552702/
https://www.ncbi.nlm.nih.gov/pubmed/37681488
http://dx.doi.org/10.3892/ijo.2023.5570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552702/
https://www.ncbi.nlm.nih.gov/pubmed/37681488
http://dx.doi.org/10.3892/ijo.2023.5570

Ejemplares similares